Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION - ACRO BIOMEDICAL CO., LTD. | acbm_ex311.htm |
EX-10.2 - PURCHASE CONTRACT - ACRO BIOMEDICAL CO., LTD. | acbm_ex102.htm |
EX-10.1 - PURCHASE CONTRACT - ACRO BIOMEDICAL CO., LTD. | acbm_ex101.htm |
10-K/A - FORM 10-K/A - ACRO BIOMEDICAL CO., LTD. | acbm_10ka.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-K/A for the year ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Pao-Chi Chu, chief executive officer of the Company, and acting chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
|
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January16, 2018 |
By: | /s/ Pao-Chi Chu | |
|
|
Pao-Chi Chu |
|
Chief Executive Officer and Chief Financial Officer |
|||
(Principal Executive, Financial and Accounting Officer) |